CN112401238A - 防治高尿酸血症和痛风的药膳食疗组合物及其制备方法 - Google Patents
防治高尿酸血症和痛风的药膳食疗组合物及其制备方法 Download PDFInfo
- Publication number
- CN112401238A CN112401238A CN202011329370.1A CN202011329370A CN112401238A CN 112401238 A CN112401238 A CN 112401238A CN 202011329370 A CN202011329370 A CN 202011329370A CN 112401238 A CN112401238 A CN 112401238A
- Authority
- CN
- China
- Prior art keywords
- parts
- gout
- preventing
- treating hyperuricemia
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000001431 Hyperuricemia Diseases 0.000 title claims abstract description 47
- 201000005569 Gout Diseases 0.000 title claims abstract description 46
- 235000005911 diet Nutrition 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000037213 diet Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 34
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 20
- 244000197580 Poria cocos Species 0.000 claims abstract description 19
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 17
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 17
- 229960000304 folic acid Drugs 0.000 claims abstract description 17
- 235000019152 folic acid Nutrition 0.000 claims abstract description 17
- 239000011724 folic acid Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 16
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 16
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 15
- 241000219784 Sophora Species 0.000 claims abstract description 15
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 14
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 14
- 241000234435 Lilium Species 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 14
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 14
- 235000004347 Perilla Nutrition 0.000 claims abstract description 13
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 6
- 241000219780 Pueraria Species 0.000 claims abstract description 5
- 241000723343 Cichorium Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 244000046146 Pueraria lobata Species 0.000 claims description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 6
- 241000282461 Canis lupus Species 0.000 claims description 5
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 230000000378 dietary effect Effects 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 235000007882 dietary composition Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 230000009471 action Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 208000017667 Chronic Disease Diseases 0.000 abstract description 2
- 244000298479 Cichorium intybus Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- 229940116269 uric acid Drugs 0.000 description 13
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 12
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 102100033220 Xanthine oxidase Human genes 0.000 description 7
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 108010093894 Xanthine oxidase Proteins 0.000 description 6
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 4
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000008777 kaempferol Nutrition 0.000 description 3
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 3
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 3
- 235000009498 luteolin Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 102000055025 Adenosine deaminases Human genes 0.000 description 2
- 241001105098 Angelica keiskei Species 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000008800 isorhamnetin Nutrition 0.000 description 2
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- IVCZEZUJCMWBBR-UHFFFAOYSA-N 7-O-beta-D-glucopyranosyl-7,3',4'-trihydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 IVCZEZUJCMWBBR-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- KMOUJOKENFFTPU-UHFFFAOYSA-N Apigenin-7-glucosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010018634 Gouty Arthritis Diseases 0.000 description 1
- 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 description 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 108010019437 Janus Kinase 2 Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000013013 Member 2 Subfamily G ATP Binding Cassette Transporter Human genes 0.000 description 1
- 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108091008099 NLRP3 inflammasome Proteins 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 108091006735 SLC22A2 Proteins 0.000 description 1
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 1
- 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- KMOUJOKENFFTPU-QNDFHXLGSA-N apigenin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-QNDFHXLGSA-N 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000004526 exfoliative dermatitis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- QZOVLVSTWSTHQN-UHFFFAOYSA-N luteolin 7-O-glucoside Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(C(=O)c3c2)c4ccc(O)c(O)c4)C(O)C(O)C1O QZOVLVSTWSTHQN-UHFFFAOYSA-N 0.000 description 1
- KBGKQZVCLWKUDQ-UHFFFAOYSA-N luteolin-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 KBGKQZVCLWKUDQ-UHFFFAOYSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical class [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 231100000483 muscle toxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000009745 pathological pathway Effects 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000007076 release of cytoplasmic sequestered NF-kappaB Effects 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供一种防治高尿酸血症和痛风的药膳食疗组合物,由以下重量份的原料制备而成:菊苣1~15份,神仙草1~15份,余甘子1~20份,槐米1~15份,野葛根1~20份,紫苏1~15份,野菊花1~10份,桑叶1~15份,乌梅1~15份,茯苓1~20份,百合1~20份,叶酸0.1~1份,壳寡糖0.1~1.5份,低聚木糖0.5~5份。以及,提供上述防治高尿酸血症和痛风的药膳食疗组合物的制备方法。所述防治高尿酸血症和痛风的药膳食疗组合物疗效明确、作用靶点和药理效应清晰、原料来源广、成本低、制备方法简单,可以多成分、多靶点、多途径、多角度干预痛风与高尿血酸症各个环节,协同防治这种慢性疾病。
Description
技术领域
本发明属于保健品技术领域,具体涉及一种防治高尿酸血症和痛风的药膳食疗组合物及其制备方法。
背景技术
高尿酸血症(hyperruriceemia,HUA)是指在正常嘌呤饮食状态下非同日两次空腹血尿酸水平男性高于420μmol/L、女性高于360μmol/L。尿酸长期升高常导致关节炎性破坏出现痛风和肾功能受损。最新研究显示我国高尿酸血症的患病率为16.85%,高尿酸血症患者已达2.36亿。
目前西医降尿酸药物不良反应大,常伴明显的胃肠道反应、肝肾功能损害、神经毒性及肌肉毒性,严重者出现剥脱性皮炎。
中医治疗本病具有临床疗效确切、安全性高、毒副作用小等优点。中医药被认为对高尿酸、痛风的疗效明确,除了临床方剂外,中成药也被推荐用于高高尿酸痛风的防治,如痛风定片、痛风舒片,复方伸筋胶囊、四妙丸等,但是这些都属于药物类产品,这些药品需要在临床医生或者药师的指导下用药。相关药食同源类产品较少。因此,药食同源降尿酸防治痛风的产品有着广阔的前景。
发明内容
本发明所要解决的技术问题在于克服现有技术之缺陷,提供一种防治高尿酸血症和痛风的药膳食疗组合物及其制备方法。
本发明提供一种防治高尿酸血症和痛风的药膳食疗组合物,由以下重量份的原料制备而成:
菊苣1~15份,
神仙草1~15份,
余甘子1~20份,
槐米1~15份,
野葛根1~20份,
紫苏1~15份,
野菊花1~10份,
桑叶1~15份,
乌梅1~15份,
茯苓1~20份,
百合1~20份,
叶酸0.1~1份,
壳寡糖0.1~1.5份,
低聚木糖0.5~5份。
以及,一种防治高尿酸血症和痛风的药膳食疗组合物的制备方法,其包括如下步骤:
按照上述防治高尿酸血症和痛风的药膳食疗组合物的重量份称取原料,将菊苣、神仙草、余甘子、槐米、野葛根、紫苏、野菊花、桑叶、乌梅、茯苓和百合混合,加10~20倍质量份的水浸泡15~60分钟,加热回流提取0.5~2小时,80~200目过滤,得第一提取液;
向药渣中加10~20倍质量份的水回流提取0.5~2小时,80~200目过滤,得第二提取液;
将第一提取液和第二提取液混合,浓缩,加入叶酸、壳寡糖和低聚木糖,获得所述防治高尿酸血症和痛风的药膳食疗组合物。
本发明的防治高尿酸血症和痛风的药膳食疗组合物,化浊利湿、降酸防痹。防治高尿酸血症与痛风,对尿酸生成的二个关键靶点腺苷脱氨酶(ADA)和黄嘌呤氧化酶(XOD)均有明显抑制活性,并显著增强尿酸排泄核心靶点尿酸转运蛋白的表达。该防治高尿酸血症和痛风的药膳食疗组合物具有疗效明确、使用方便、作用靶点和药理效应清晰、原料来源广、成本低、制备方法简单、患者依从性高等特点,适用人群为高尿酸血症与通风的病患者。
附图说明
图1是本发明实施例提供的防治高尿酸血症和痛风的药膳食疗组合物的中药原料-活性成分-作用靶点关联网络图。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
本发明实施例提供一种防治高尿酸血症和痛风的药膳食疗组合物,由以下重量份的原料制备而成:
菊苣1~15份,
神仙草1~15份,
余甘子1~20份,
槐米1~15份,
野葛根1~20份,
紫苏1~15份,
野菊花1~10份,
桑叶1~15份,
乌梅1~15份,
茯苓1~20份,
百合1~20份,
叶酸0.1~1份,
壳寡糖0.1~1.5份,
低聚木糖0.5~5份。
其中,菊苣、神仙草和槐米中的槲皮素等均可抑制炎症因子TNFα和IL-1β等释放、抑制NF-κB、NLRP3炎性小体激活,对抗monosodium urate crystals诱导的啮齿类动物痛风关节炎。野葛根中的葛根素以及山奈提取物可提高抗氧化机能、抑制黄嘌呤氧化酶(xanthine oxidase,直接催化黄嘌呤生成尿酸的酶)、减少尿酸形成、促进尿酸代谢。野菊花中的luteolin-7-O-glucoside,apigenin-7-O-glucoside,木犀草素和芹菜素亦被证明是黄嘌呤氧化酶的抑制剂,IC50分别为23.61,38.80,1.54,1.96μM,提示野菊花可抑制尿酸形成,预防高尿酸血症。分子对接实验进一步证实,诸多中药(如山奈、乌梅、槐米)包含的活性成分山奈酚占据黄嘌呤氧化酶的催化活性位点,竞争性可逆抑制黄嘌呤氧化酶。网络药理学研究提示:该防治高尿酸血症和痛风的药膳食疗组合物能多成分、多靶点、多途径、多角度干预痛风与高尿血酸症各个环节,协同防治这种慢性疾病。该处方全部采用食品级原料,安全有效,生产成本底,预防效果可靠,其可以有效地防治高高尿酸痛风引起的相关症状,是一款主成分清晰,靶点明确的精准药膳产品。
优选地,所述防治高尿酸血症和痛风的药膳食疗组合物由以下重量份的原料制备而成:菊苣8~10份,神仙草5~7份,余甘子8~10份,槐米8~10份,野葛根8~10份,紫苏8~10份,野菊花5~7份,桑叶8~10份,乌梅5~7份,茯苓8~10份,百合8~10份,叶酸0.2~0.4份,壳寡糖0.4~0.6份,低聚木糖0.8~1.2份。更具体地,所述防治高尿酸血症和痛风的药膳食疗组合物由以下重量份的原料制备而成:菊苣9份,神仙草6份,余甘子9份,槐米9份,野葛根9份,紫苏9份,野菊花6份,桑叶9份,乌梅6份,茯苓9份,百合9份,叶酸0.3份,壳寡糖0.5份,低聚木糖1份。该处方全部采用食品级原料,安全有效,生产成本底,预防效果可靠。如图1所示,网络药理学研究初步明确了主治病症-靶点-药效成分作用关系网络,明确了参与作用的生理/病理通路过程,同时,所述防治高尿酸血症和痛风的药膳食疗组合物的成分-靶点-药理作用机制网络研究结果与主治病症衔接一致,符合现代精准医学原则。由于网络药理学关系图空间布局限制,用英文名称或缩写代替,具体中英文对应如表1所示。
表1
英文名 | 中文名 | 英文名 | 中文名 |
daidzein | 黄豆苷元 | Vitamin B12 | 维生素B12 |
Emodin | 大黄素 | Xylo-oligosaccharide | 低聚木糖 |
folic acid | 叶酸 | ABCG2 | 三磷酸腺苷结合转运蛋白G2 |
formononetin | 芒柄花黄素 | JAK2 | 酪氨酸Janus激酶2 |
Isorhamnetin | 异鼠李素 | PPARG | 过氧化物酶体增殖剂激活受体γ |
kaempferol | 山柰酚 | SLC22A2 | 溶质载体家族22 |
luteolin | 木犀草素 | STAT3 | 信号传导蛋白和转录激活物3 |
Puerarin | 葛根素 | XDH | 黄嘌呤脱氢酶 |
quercetin | 槲皮素 |
此外,本品成本低,符合产业化生产需要。
本发明实施例还提供上述防治高尿酸血症和痛风的药膳食疗组合物的制备方法,其包括如下步骤:
按照上述防治高尿酸血症和痛风的药膳食疗组合物的重量份称取原料,将菊苣、神仙草、余甘子、槐米、野葛根、紫苏、野菊花、桑叶、乌梅、茯苓和百合混合,加10~20倍质量份的水浸泡15~60分钟,加热回流提取0.5~2小时,80~200目过滤,得第一提取液;
向药渣中加10~20倍质量份的水回流提取0.5~2小时,80~200目过滤,得第二提取液;
将第一提取液和第二提取液混合,浓缩,加入叶酸、壳寡糖和低聚木糖,获得所述防治高尿酸血症和痛风的药膳食疗组合物。
优选地,按照上述防治高尿酸血症和痛风的药膳食疗组合物的重量份称取原料,将菊苣、神仙草、余甘子、槐米、野葛根、紫苏、野菊花、桑叶、乌梅、茯苓和百合混合,加10~20倍质量份的水浸泡20~40分钟,加热回流提取1小时,100~200目过滤,得第一提取液;
向药渣中加10~15倍质量份的水,加热回流提取0.5~2小时,100~200目过滤,得第二提取液。
更具体地,所述防治高尿酸血症和痛风的药膳食疗组合物,两次提取液的混合液减压浓缩至密度约为1.08,得浓缩液备用;浓缩液加入麦芽糊精,搅拌均匀,喷雾干燥(喷嘴进风温度设为150度,出风口温度80度),即得提取物粉末,备用。
取上述喷干粉加入叶酸、壳寡糖和低聚木糖,混合均匀;分装,10g/袋,即得固体饮料。
或者,以上述喷雾干燥的粉末加入叶酸、壳寡糖和低聚木糖,进行制粒,干燥,分装、10g/袋,制备成颗粒剂。
采用喷干粉,加入叶酸、壳寡糖和低聚木糖等适宜的食品原料,进行制粒,干燥,压片;做成适宜的片剂形式即可。
产品的最终形式可以是多种,包括粉剂、颗粒、片剂、蜜丸、膏滋、口服液、糖浆剂等。制备工艺中,干燥方式可以是喷雾干燥、真空干燥、冷冻干燥等;制粒方法可以是干法制粒、湿法制粒、一步制粒等。
采用药学、食品、保健品等相关法规可以接受的方法,均可以对上述防治高尿酸血症和痛风的药膳食疗组合物进行提取、浓缩、干燥或粉碎,进一步加工为产品,保留复方的有效成分,制成适宜的给药形式(包括颗粒剂、粉剂、口服液、片剂等剂型)或者食品形式如压片糖果、餐粉、固体饮料等形式,满足市场对相关产品的需求,均属于本发明保护的范围。
以下通过具体配方和制备工艺的实施例来说明上述防治高尿酸血症和痛风的药膳食疗组合物及其制备方法。
实施例1:
称取菊苣9kg,神仙草6kg,余甘子9kg,槐米9kg,野葛根9kg,紫苏9kg,野菊花6kg,桑叶9kg,乌梅6kg,茯苓9kg,百合9kg,混合,加水15倍浸泡30分钟,加热回流提取1小时,200目过滤,药渣加10倍水回流提取1小时;合并滤液,减压浓缩密度约为1.08,加入麦芽糊精适量,喷雾干燥,即得提取物;加入叶酸0.3kg,壳寡糖0.5kg,低聚木糖1.0kg,混合均匀,上粉末包装机,分装,制成固体饮料,10g/袋。
实施例2:
选择100位高尿酸患者作为保健品每日服用上述防治高尿酸血症和痛风的药膳食疗组合物制备方法制备的固体饮料,每天2~3次;每次取本品一袋,加入100~200毫升热水冲调搅至溶解后,食用。连服两周,有70%以上患者的尿酸有不同程度的降低。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种防治高尿酸血症和痛风的药膳食疗组合物,其特征在于,所述药膳食疗组合物由以下重量份的原料制备而成:
菊苣1~15份,
神仙草1~15份,
余甘子1~20份,
槐米1~15份,
野葛根1~20份,
紫苏1~15份,
野菊花1~10份,
桑叶1~15份,
乌梅1~15份,
茯苓1~20份,
百合1~20份,
叶酸0.1~1份,
壳寡糖0.1~1.5份,
低聚木糖0.5~5份。
2.如权利要求1所述的防治高尿酸血症和痛风的药膳食疗组合物,其特征在于,所述药膳食疗组合物由以下重量份的原料制备而成:
菊苣8~10份,
神仙草5~7份,
余甘子8~10份,
槐米8~10份,
野葛根8~10份,
紫苏8~10份,
野菊花5~7份,
桑叶8~10份,
乌梅5~7份,
茯苓8~10份,
百合8~10份,
叶酸0.2~0.4份,
壳寡糖0.4~0.6份,
低聚木糖0.8~1.2份。
3.如权利要求2所述的防治高尿酸血症和痛风的药膳食疗组合物,其特征在于,所述药膳食疗组合物由以下重量份的原料制备而成:
菊苣9份,
神仙草6份,
余甘子9份,
槐米9份,
野葛根9份,
紫苏9份,
野菊花6份,
桑叶9份,
乌梅6份,
茯苓9份,
百合9份,
叶酸0.3份,
壳寡糖0.5份,
低聚木糖1份。
4.一种防治高尿酸血症和痛风的药膳食疗组合物的制备方法,其特征在于,包括如下步骤:
按照权利要求1~3任一所述的防治高尿酸血症和痛风的药膳食疗组合物的重量份称取原料,将菊苣、神仙草、余甘子、槐米、野葛根、紫苏、野菊花、桑叶、乌梅、茯苓和百合混合,加10~20倍质量份的水浸泡15~60分钟,加热回流提取0.5~2小时,80~200目过滤,得第一提取液;
向药渣中加10~20倍质量份的水回流提取0.5~2小时,80~200目过滤,得第二提取液;
将第一提取液和第二提取液混合,浓缩,加入叶酸、壳寡糖和低聚木糖,获得所述防治高尿酸血症和痛风的药膳食疗组合物。
5.如权利要求4所述的防治高尿酸血症和痛风的药膳食疗组合物的制备方法,其特征在于,将菊苣、神仙草、余甘子、槐米、野葛根、紫苏、野菊花、桑叶、乌梅、茯苓和百合混合,加12~15倍质量份的水浸泡25~35分钟。
6.如权利要求4所述的防治高尿酸血症和痛风的药膳食疗组合物的制备方法,其特征在于,向药渣中加10~15倍质量份的水。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2020/139693 WO2022021778A1 (zh) | 2020-07-28 | 2020-12-25 | 防治高尿酸血症和痛风的药膳食疗组合物及其制备方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010739811 | 2020-07-28 | ||
CN2020107398119 | 2020-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112401238A true CN112401238A (zh) | 2021-02-26 |
Family
ID=74778027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011329370.1A Withdrawn CN112401238A (zh) | 2020-07-28 | 2020-11-24 | 防治高尿酸血症和痛风的药膳食疗组合物及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112401238A (zh) |
WO (1) | WO2022021778A1 (zh) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1323675C (zh) * | 2004-01-19 | 2007-07-04 | 张冰 | 菊苣水提取物的新用途 |
CN104546995B (zh) * | 2014-12-23 | 2018-06-19 | 苏州凯祥生物科技有限公司 | 一种余甘子提取物的药物用途 |
CN104922176B (zh) * | 2015-06-10 | 2019-04-12 | 浙江中医药大学 | 一种野菊花提取物的应用 |
CN106474185A (zh) * | 2015-08-26 | 2017-03-08 | 国药集团健康产业研究院有限公司 | 一种紫苏叶提取物及其组合物在制备降低血尿酸的药物或食品中的应用 |
CN105055510B (zh) * | 2015-09-14 | 2019-11-15 | 青岛大学 | 紫苏叶抗高尿酸血症有效部位及其制备方法和应用 |
CN107050324A (zh) * | 2017-01-26 | 2017-08-18 | 赵杏珍 | 一种防治痛风及降三高的药食同源中药功能养生排毒饮品 |
CN108143907A (zh) * | 2018-02-01 | 2018-06-12 | 广州御草方生物科技有限公司 | 保健茶制剂及其制备方法和应用 |
CN108477438A (zh) * | 2018-03-26 | 2018-09-04 | 江苏江大基因生物科技有限公司 | 一种高尿酸血症和痛风患者的专用解酒饮料及其制备方法 |
CN108403987A (zh) * | 2018-05-11 | 2018-08-17 | 刘松松 | 一种防治痛风的菊苣栀子茶 |
CN110141638A (zh) * | 2019-05-30 | 2019-08-20 | 江西虔农农业股份有限公司 | 一种用于调理痛风的中药组合物和应用 |
-
2020
- 2020-11-24 CN CN202011329370.1A patent/CN112401238A/zh not_active Withdrawn
- 2020-12-25 WO PCT/CN2020/139693 patent/WO2022021778A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022021778A1 (zh) | 2022-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109674958B (zh) | 一种具有降尿酸功效的中药组合物及其制备方法和应用 | |
CN104069335A (zh) | 一种改善睡眠的药物组合物及制备方法和应用 | |
US10821149B2 (en) | Composition and the use thereof | |
CN112168876A (zh) | 一种具有降血脂作用的组合物及其制备方法和应用 | |
CN103191235A (zh) | 一种用于预防和治疗高尿酸血症的中药复方提取物及应用 | |
CN100374129C (zh) | 树莓叶提取物的有效部位和其组合物及其应用 | |
CN101143202A (zh) | 一种对化学性肝损伤具有保护作用的复方口服制剂 | |
CN112385841A (zh) | 一种用于2型糖尿病的药膳食疗组合物及其制备方法 | |
CN111870627A (zh) | 一种解酒制剂及其制备方法和用途 | |
CN110680902A (zh) | 一种用于治疗蛋鸡脂肪肝中药组合物 | |
CN112401238A (zh) | 防治高尿酸血症和痛风的药膳食疗组合物及其制备方法 | |
CN102552871A (zh) | 一种鞣酸蛋白酵母咀嚼片及其生产方法 | |
AU2021106230A4 (en) | Medicinal diet composition for preventing and treating hyperuricemia and gout and preparation method thereof | |
CN102836334A (zh) | 一种兽用补气健脾的中药制剂 | |
CN113384612A (zh) | 一种抗痛风组合物及其制备方法和应用 | |
KR101154031B1 (ko) | 혼합 생약재 추출물을 유효성분으로 함유하는 피로회복용 조성물 | |
CN111870661A (zh) | 一种用于新冠肺炎初期轻症的中药组合物及其制备方法 | |
CN100589814C (zh) | 降脂药物组合物及其制备方法 | |
CN102599312B (zh) | 低聚糖三七甜茶及其制备方法 | |
WO2010037255A1 (zh) | 一种人参绞股蓝复方制剂在制备调节血脂、血糖的药物中的用途 | |
CN111939238A (zh) | 一种抗毒防感避疫中药保健组合物及其制备方法 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN111939211A (zh) | 用于新冠感染中期辅助治疗的中药组合物及其制备方法 | |
CN115919927B (zh) | 一种中药组合物及应用 | |
CN110585254A (zh) | 一种原生态人参含嚼片、颗粒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210226 |
|
WW01 | Invention patent application withdrawn after publication |